Is HRT Safe? HRT Facts and Myths, Explained

What the 2024 NICE guidance and modern evidence actually say about breast cancer, blood clots and stroke — and the myths that persist from 2002.

Part of the Complete Hormone Replacement Therapy Guide.

Few medicines carry as much unnecessary fear as hormone replacement therapy. Much of that fear traces back to a single 2002 study whose findings were widely misreported — and whose conclusions have since been substantially revised. This guide separates what the current evidence actually shows from the myths that persist, drawing on NICE guideline NG23 (updated November 2024) and the British Menopause Society.

For a general introduction, start with What is HRT? or our full Hormone Replacement Therapy guide.

The short answer

For most healthy women under 60 who start HRT within 10 years of menopause, the benefits outweigh the risks. That is the position of NICE, the British Menopause Society and the NHS. Risk is not zero — but it is small, it varies by HRT type and route, and it must be weighed against the real harms of untreated symptoms and bone loss.

Why the fear? The 2002 WHI study

The Women's Health Initiative study linked HRT to breast cancer and heart disease, and prescriptions collapsed worldwide. But the study tested one specific combination — oral conjugated equine oestrogen plus a synthetic progestogen — in women who were on average 63 years old, many years past menopause. Its findings were then applied to all HRT in all women. Re-analysis showed that for younger women starting near menopause, the picture is very different, and NICE's guidance now takes an individualised approach rather than a blanket warning.

Fact-checking the big three risks

Breast cancer

Fact: Combined HRT (oestrogen + progestogen) is associated with a small increased risk after around 5 years of use — roughly 5 extra cases per 1,000 women over 5 years of use, based on the 2019 Lancet meta-analysis. Oestrogen-only HRT shows little to no increase in most studies. For context, being overweight or drinking 2+ units of alcohol daily carries a comparable or greater risk. The increase declines after stopping.

Myth: "HRT causes breast cancer in most women who take it." The absolute risk for an individual woman under 60 is small, and lifestyle factors are of a similar order of magnitude.

Blood clots (VTE)

Fact: Oral HRT carries a small increased clot risk. Transdermal HRT — patches, gels, spray — shows no significant increase versus non-users. This is why prescribers often favour skin-based HRT, especially for women with a higher BMI or clot history.

Myth: "All HRT causes blood clots." The route matters; the risk is essentially confined to tablets.

Stroke

Fact: Oral oestrogen is associated with a small increase in ischaemic stroke risk, mainly in older women starting HRT late. Transdermal HRT at standard doses has not shown a significant increase.

Myth: "HRT causes strokes at any age." Starting before 60, particularly with transdermal HRT, the evidence does not support a meaningful increase.

What the November 2024 NICE update changed

The first major revision of NG23 in nearly a decade reviewed the evidence on HRT's long-term health outcomes, added cognitive behavioural therapy (CBT) as a recommended option for vasomotor symptoms and menopause-related sleep problems, and updated guidance on managing genitourinary symptoms. It reaffirmed individualised, shared decision-making on HRT rather than fixed rules. If you'd rather avoid hormones, see our alternatives to HRT guide.

Other persistent myths

"HRT causes weight gain."

Menopause itself shifts fat storage toward the abdomen as oestrogen falls. Trials show no significant weight difference between HRT users and non-users; HRT may help preserve body composition.

"You can only take HRT for 5 years."

There is no fixed maximum in NICE guidance. Duration is decided at annual review based on your symptoms and risk profile.

"You must stop HRT at 60."

Age alone is not a reason to stop. Many women continue safely beyond 60, often on transdermal regimens, following individual review.

"Natural or compounded 'bioidentical' hormones are safer."

Unregulated compounded bioidentical HRT is not recommended by UK regulators or menopause societies. Regulated body-identical HRT (transdermal estradiol + micronised progesterone) is available on prescription — see our body-identical HRT guide.

Who should be cautious

If you're weighing up HRT, Access Doctor's pharmacist independent prescribers can talk through your personal risk profile in a confidential online consultation and, where appropriate, prescribe with discreet next-day delivery.